pI: 10.4015 |
Length (AA): 350 |
MW (Da): 41363 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130049)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_52170 | hypothetical protein |
Brugia malayi | Bm1_52175 | Protein kinase domain containing protein |
Candida albicans | CaO19.3776 | MAP kinase kinase kinase |
Candida albicans | CaO19.11257 | MAP kinase kinase kinase |
Candida albicans | CaO19.3775 | similar to MAP kinase kinase kinase |
Caenorhabditis elegans | CELE_B0414.7 | Protein MTK-1, isoform A |
Drosophila melanogaster | Dmel_CG7717 | CG7717 gene product from transcript CG7717-RB |
Homo sapiens | ENSG00000085511 | mitogen-activated protein kinase kinase kinase 4 |
Loa Loa (eye worm) | LOAG_05861 | STE/STE11/MEKK4 protein kinase |
Loa Loa (eye worm) | LOAG_05860 | hypothetical protein |
Mus musculus | ENSMUSG00000014426 | mitogen-activated protein kinase kinase kinase 4 |
Onchocerca volvulus | OVOC6501 |
|
Saccharomyces cerevisiae | YNR031C | Ssk2p |
Saccharomyces cerevisiae | YCR073C | Ssk22p |
Schmidtea mediterranea | mk4.000879.02 | Mitogen-activated protein kinase kinase kinase 4 |
Schmidtea mediterranea | mk4.010967.02 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_B0414.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase kinase kinase 4 | Compounds | References |